Protara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 805 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 76-100 of 800 matching filings.

Per page
25
Current page
4
S-8 File 333-289494

REGISTRATION STATEMENT

Filing date
11 Aug 2025
Reporting date
Not listed
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
11 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
11 Aug 2025
Reporting date
11 Aug 2025
Next action
Verify source filing
SCHEDULE 13G File 005-88372

SCHEDULE 13G filing

Filing date
17 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jul 2025
Reporting date
24 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Jun 2025
Reporting date
26 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2025
Reporting date
12 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
12 Jun 2025
Reporting date
11 Jun 2025
Next action
Verify source filing
4

4 filing

Filing date
04 Jun 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
04 Jun 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
19 May 2025
Reporting date
14 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 May 2025
Reporting date
14 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
12 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
08 May 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
08 May 2025
Reporting date
08 May 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-279067

PROSPECTUS SUPPLEMENT

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .